Madhavan  Balachandran net worth and biography

Madhavan Balachandran Biography and Net Worth

Director of Stevanato Group

Holding a master’s degree in Chemical Engineering from the State University of New York at Buffalo and an MBA from East Carolina University, Madhavan is Chief Operating Officer of Nutcracker Therapeutics, a developer of mRNA therapeutics, a position he has held since September 2020. He previously served as Chief Executive Officer of ADRx, Inc., a pre-clinical stage biotechnology company since August 2019. Prior to that, he was Executive Vice President, Operations of Amgen Inc. from August 2012 until July 2016 and retired as an Executive Vice President in January 2017, having served in various management positions since joining the company in 1997. Prior to his tenure at Amgen, Madhavan held leadership positions at Copley Pharmaceuticals, now a part of Teva Pharmaceuticals Industries Ltd. and Burroughs Welcome Company, a predecessor before mergers of GlaxoSmithKline plc. He currently serves as a director in Catalent Inc. and uniQure NV. He has been a member of the board of directors of Stevanato Group since 2018.

What is Madhavan Balachandran's net worth?

The estimated net worth of Madhavan Balachandran is at least €1.22 million as of June 15th, 2026. Balachandran owns 69,458 shares of Stevanato Group stock worth more than $1,222,461 as of June 26th. This net worth approximation does not reflect any other investments that Balachandran may own. Learn More about Madhavan Balachandran's net worth.

How do I contact Madhavan Balachandran?

The corporate mailing address for Balachandran and other Stevanato Group executives is PIOMBINO DESE (PD) VIA MOLINELLA 17, PADUA L6, 35017. Stevanato Group can also be reached via phone at 39049931811 and via email at [email protected]. Learn More on Madhavan Balachandran's contact information.

Has Madhavan Balachandran been buying or selling shares of Stevanato Group?

During the last quarter, Madhavan Balachandran has sold €25,515.37 in Stevanato Group stock. Most recently, Madhavan Balachandran sold 1,493 shares of the business's stock in a transaction on Monday, June 15th. The shares were sold at an average price of €17.09, for a transaction totalling €25,515.37. Following the completion of the sale, the director now directly owns 69,458 shares of the company's stock, valued at €1,187,037.22. Learn More on Madhavan Balachandran's trading history.

Who are Stevanato Group's active insiders?

Stevanato Group's insider roster includes Madhavan Balachandran (Director), William Federici (Director), Karen Flynn (Director), and E Jr (Director). Learn More on Stevanato Group's active insiders.

Are insiders buying or selling shares of Stevanato Group?

During the last year, insiders at the sold shares 4 times. They sold a total of 5,972 shares worth more than €102,061.48. The most recent insider tranaction occured on June, 15th when Director Madhavan Balachandran sold 1,493 shares worth more than €25,515.37. Insiders at Stevanato Group own 0.7% of the company. Learn More about insider trades at Stevanato Group.

Information on this page was last updated on 6/15/2026.

Madhavan Balachandran Insider Trading History at Stevanato Group

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/15/2026Sell1,493€17.09€25,515.3769,458View SEC Filing Icon  
See Full Table

Madhavan Balachandran Buying and Selling Activity at Stevanato Group

This chart shows Madhavan Balachandran's buying and selling at Stevanato Group by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Stevanato Group Company Overview

Stevanato Group logo
Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. is a subsidiary of Stevanato Holding S.R.L.
Read More

Today's Range

Now: €17.79
Low: €17.35
High: €18.67

50 Day Range

MA: €17.41
Low: €14.69
High: €19.03

2 Week Range

Now: €17.79
Low: €12.89
High: €28.00

Volume

327,959 shs

Average Volume

588,580 shs

Market Capitalization

€5.39 billion

P/E Ratio

30.15

Dividend Yield

N/A

Beta

0.78